Skip to main content
Equibles
OMCL logo

OMCL · Omnicell, Inc. · Metrics

Track OMCL — free

Use OMCL with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research OMCL.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$33.28 +0.49 (+1.49%)
S&P 600 member Russell 2000 member Rebalance outlook locked
Market Cap
$1.50B
Shares
45.61M

OMCL metrics

87 of 115 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$32.79
Market cap
$1.50B

Price action

20 metrics
Price change (1W)
-4.6%
Price change (30D)
-9.0%
Price change (3M)
-13.3%
Price change (6M)
-4.7%
Price change (YTD)
-27.6%
Price change (1Y)
-1.5%
Trailing year
Price change (5Y)
-79.5%
52-week high
$51.39
52-week low
$29.46
Change from 52-week high
-36.2%
Change from 52-week low
+11.3%
Annualized volatility
50.7%
Annualized volatility (3M)
47.1%
Beta
1.0
RSI (14D)
35.8
Price vs SMA 50
-15.2%
Price vs SMA 200
-19.4%
Avg volume (3M)
753,725
Relative volume
0.6
Average dollar volume
$29.27M

Company

3 metrics
Sector
Healthcare
Industry
Health Information Services
Shares outstanding
45.61M

Valuation

12 metrics
P / E (TTM)
39.0
Trailing earnings · reciprocal yield 2.6%
PEG ratio
0.1
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
1.2×
reciprocal yield 83.4%
P / book
1.2
reciprocal yield 86.4%
FCF yield
9.5%
TTM · current market cap
Buyback yield
4.1%
P / FCF
10.5
reciprocal yield 9.5%
P / operating cash flow
8.2
reciprocal yield 12.1%
Earnings yield
2.6%

Historical valuation

8 metrics
P / E historical average (3Y)
219.0×
reciprocal yield 0.5%
P / E historical average (5Y)
180.0×
reciprocal yield 0.6%
EV / revenue historical average (3Y)
4.5×
reciprocal yield 22.3%
EV / revenue historical average (5Y)
4.5×
reciprocal yield 22.3%
EV / EBIT historical average (3Y)
87.2×
reciprocal yield 1.1%
EV / EBIT historical average (5Y)
87.2×
reciprocal yield 1.1%
EV / EBITDA historical average (3Y)
34.9×
reciprocal yield 2.9%
EV / EBITDA historical average (5Y)
34.9×
reciprocal yield 2.9%

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
4.1%
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-07-30

Profitability

9 metrics
Gross margin
44.8%
Operating margin
4.6%
Trailing 12 months
Net margin
3.1%
Gross profit (TTM)
$558.13M
Operating profit (TTM)
$57.96M
Net income (TTM)
$39.08M
Trailing 12 months
Diluted EPS (TTM)
$0.84
FCF margin
11.4%
Effective tax rate
36.1%

Per share

11 metrics
Revenue per diluted share (TTM)
—
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
—
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
—
Operating cash flow per diluted share (TTM)
—
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
—
Book value per share
$27.36

Growth

11 metrics
Revenue growth YoY
+7.4%
Year over year
Net income growth YoY
+330.7%
Revenue (TTM)
$1.25B
Trailing 12 months
EPS growth YoY
+333.3%
Shares change YoY
-1.5%
Year over year · fewer shares
Revenue CAGR (3Y)
-2.9%
Revenue CAGR (5Y)
+5.8%
EPS CAGR (3Y)
-30.7%
EPS CAGR (5Y)
-44.2%
FCF CAGR (3Y)
+42.2%
FCF CAGR (5Y)
-11.8%

Quality

14 metrics
Return on equity
3.0%
Return on assets
2.0%
Debt / equity
—
Current ratio
1.6
EBITDA (TTM)
$134.53M
Free cash flow (TTM)
$142.60M
Quick ratio
1.4
Interest coverage
—
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Cash & equivalents
$292.17M
Total assets
$2.00B
Total debt
—

Cash flow & spend

7 metrics
Operating cash flow (TTM)
$181.44M
Capital expenditures (TTM)
$38.84M
R&D (TTM)
$88.39M
SG&A (TTM)
$411.77M
Stock compensation (TTM)
$44.89M
R&D / revenue
7.1%
Stock compensation / revenue
3.6%

Ownership (13F)

3 metrics
13F filers
307
13F filer change QoQ
+32
Institutional ownership
106.1%

Short interest

3 metrics
Short interest
7.2%
Latest settlement · 4.8 days to cover
Days to cover
4.8d
Short-squeeze score
54 / 100

Insider activity

2 metrics
Net insider buying (90D)
−$583,609
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
—
Key facts CIK 926326 CUSIP 68213N109 13F (30d) 19 filings 19 filers Visit website Investor relations